Filing Details

Accession Number:
0001179110-18-009302
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 14:32:38
Reporting Period:
2018-06-29
Accepted Time:
2018-07-03 14:32:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280600 Acceleron Pharma Inc XLRN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214938 F Kevin Mclaughlin 128 Sidney Street
Cambridge MA 02139
Svp, Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-29 25,000 $24.11 68,939 No 4 M Direct
Common Stock Disposition 2018-06-29 12,500 $47.00 56,439 No 4 S Direct
Common Stock Disposition 2018-06-29 12,500 $49.00 43,939 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2018-06-29 25,000 $0.00 25,000 $24.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,000 2023-12-05 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.